The market opened higher with the Dow climbing 73 points to 15,253 as the Federal Reserve's two-day policy-setting meeting begins today. Nasdaq gained 15 points to 3467.
On the upside
Cytokinetics (Nasdaq: CYTK) will present results from a Phase IIb clinical trial of omecamtiv mecarbil during a Hot Line Late Breaking Trials Session at the European Society of Cardiology Congress 2013. Cytokinetics will also join the Russell Global Index on June 28, 2013.
Gevo (Nasdaq: GEVO) resumed commercial production of isobutanol at its facility in Minnesota.
Bargain hunters snapped up shares of Walter Energy (NYSE: WLT).
On the downside
Ship Finance International (NYSE: SFL) priced its public offering of 8 million common shares but did not disclose the price.
New Mountain Finance (NYSE: NMFC) priced its primary offering of 2 million common shares and secondary offering of 4 million common shares at the discounted price of $14.55.
Motley Fool expects MannKind's (Nasdaq: MNKD) stock price to retreat.
In the broad market, advancing issues outpaced decliners by a margin of nearly 10 to 9 on the NYSE and by nearly 5 to 3 on Nasdaq. The broader S&P 500 index rose 5 points to 1644.
